Original Research

Published on 16 Apr 2024

Designing of a multi-epitopes based vaccine against Haemophilius parainfluenzae and its validation through integrated computational approaches

in Vaccines and Molecular Therapeutics

Sana Abdul Ghaffar
Haneen Tahir
Sher Muhammad
Muhammad Shahid
Tahir Naqqash
Muhammad Faisal
Thamer H. Albekairi
Abdulrahman Alshammari
Norah A. Albekairi
Irfan Manzoor

Frontiers in Immunology

doi 10.3389/fimmu.2024.1380732

2,185 views
2 citations

Systematic Review

Published on 16 Apr 2024

Prevalence and genetic diversity of rotavirus among children under 5 years of age in China: a meta-analysis

in Vaccines and Molecular Therapeutics

Yue Li
Sijie Wang
Fan Liang
Sashuang Teng
Fei Wang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1364429

1,309 views
1 citation

Brief Research Report

Published on 12 Apr 2024

The role of cGAMP via the STING pathway in modulating germinal center responses and CD4 T cell differentiation

in Vaccines and Molecular Therapeutics

Mijung Yoon
Yurim Choi
Taeuk Wi
Youn Soo Choi
Jinyong Choi

Frontiers in Immunology

doi 10.3389/fimmu.2024.1340001

1,598 views
1 citation

Opinion

Published on 11 Apr 2024

Unifying global efforts by CEPI’s centralized laboratory network

in Vaccines and Molecular Therapeutics

Ali Azizi
Valentina Bernasconi

Frontiers in Immunology

doi 10.3389/fimmu.2024.1404309

735 views
1 citation

Original Research

Published on 08 Apr 2024

Bi-isotype immunoglobulins enhance antibody-mediated neutrophil activity against Plasmodium falciparum parasites

in Vaccines and Molecular Therapeutics

Rodney Ogwang
Lewis Murugu
Irene N. Nkumama
Lydia Nyamako
Oscar Kai
Kennedy Mwai
Linda Murungi
Richard Idro
Philip Bejon
James Tuju

Frontiers in Immunology

doi 10.3389/fimmu.2024.1360220

1,731 views

Original Research

Published on 08 Apr 2024

Outer membrane vesicles derived from Bordetella pertussis are potent adjuvant that drive Th1-biased response

in Vaccines and Molecular Therapeutics

Bernarda Pschunder
Lucia Locati
Oriana López
Pablo Martin Aispuro
Eugenia Zurita
Matthew Stuible
Yves Durocher
Daniela Hozbor

Frontiers in Immunology

doi 10.3389/fimmu.2024.1387534

1,951 views
2 citations

Original Research

Published on 05 Apr 2024

Utilizing noncatalytic ACE2 protein mutant as a competitive inhibitor to treat SARS-CoV-2 infection

in Vaccines and Molecular Therapeutics

Shengjiang Liu
Haifeng Chen
Xiangqun Chen
Ningguang Luo
Sameera Peraramelli
Xiaoming Gong
Mingwei John Zhang
Li Ou

Frontiers in Immunology

doi 10.3389/fimmu.2024.1365803

1,325 views

Original Research

Published on 05 Apr 2024

An in vitro assay for toxicity testing of Clostridium perfringens type C β-toxin

in Vaccines and Molecular Therapeutics

Marieke Hoonakker
Afshin Zariri
Lisette de Brouwer
Dionne David
Anouska Borgman
Arjen Sloots

Frontiers in Immunology

doi 10.3389/fimmu.2024.1373411

1,221 views
3 citations

Original Research

Published on 04 Apr 2024

Investigation of the safety and protective efficacy of an attenuated and marker M. bovis-BoHV-1 combined vaccine in bovines

in Vaccines and Molecular Therapeutics

Sen Zhang
Guoxing Liu
Yisheng Zhang
Chen Wang
Xiaowen Xu
Yuhao Zhao
Zhijie Xiang
Wenying Wu
Li Yang
Jianguo Chen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1367253

1,622 views
1 citation

Original Research

Published on 03 Apr 2024

Dry and liquid formulations of IBT-V02, a novel multi-component toxoid vaccine, are effective against Staphylococcus aureus isolates from low-to-middle income countries

in Vaccines and Molecular Therapeutics

Yu Wang
Ipsita Mukherjee
Arundhathi Venkatasubramaniam
Dustin Dikeman
Nicholas Orlando
Jing Zhang
Roger Ortines
Mark Mednikov
Shardulendra P. Sherchand
Tulasikumari Kanipakala

Frontiers in Immunology

doi 10.3389/fimmu.2024.1373367

1,495 views

Original Research

Published on 03 Apr 2024

Boosting the immunogenicity of the CoronaVac SARS-CoV-2 inactivated vaccine with Huoxiang Suling Shuanghua Decoction: a randomized, double-blind, placebo-controlled study

in Vaccines and Molecular Therapeutics

Ruying Tang
Linyuan Wang
Jianjun Zhang
Wenting Fei
Rui Zhang
Jinlian Liu
Meiyu Lv
Mengyao Wang
Ruilin Lv
Haipeng Nan

Frontiers in Immunology

doi 10.3389/fimmu.2024.1298471

2,010 views
2 citations

Original Research

Published on 03 Apr 2024

Whole genome sequencing of recombinant viruses obtained from co-infection and superinfection of Vero cells with modified vaccinia virus ankara vectored influenza vaccine and a naturally occurring cowpox virus

in Vaccines and Molecular Therapeutics

Diana Diaz-Cánova
Ugo Moens
Annika Brinkmann
Andreas Nitsche
Malachy Ifeanyi Okeke

Frontiers in Immunology

doi 10.3389/fimmu.2024.1277447

2,018 views

Original Research

Published on 02 Apr 2024

Clonal structure and the specificity of vaccine-induced T cell response to SARS-CoV-2 Spike protein

in Vaccines and Molecular Therapeutics

Saveliy A. Sheetikov
Alexandra A. Khmelevskaya
Ksenia V. Zornikova
Ivan V. Zvyagin
Alina S. Shomuradova
Yana V. Serdyuk
Naina T. Shakirova
Iuliia O. Peshkova
Aleksei Titov
Dmitrii S. Romaniuk

Frontiers in Immunology

doi 10.3389/fimmu.2024.1369436

2,936 views
1 citation

Brief Research Report

Published on 28 Mar 2024

Co-formulation of the rF1V plague vaccine with depot-formulated cytokines enhances immunogenicity and efficacy to elicit protective responses against aerosol challenge in mice

in Vaccines and Molecular Therapeutics

Darrell R. Galloway
Jiahui Li
Nguyen X. Nguyen
Frank W. Falkenberg
Lisa Henning
Robert Krile
Ying-Liang Chou
James N. Herron
J. Scott Hale
E. Diane Williamson

Frontiers in Immunology

doi 10.3389/fimmu.2024.1277526

1,315 views
2 citations

Original Research

Published on 28 Mar 2024

Optimizing cryopreservation conditions for use of fucosylated human mesenchymal stromal cells in anti-inflammatory/immunomodulatory therapeutics

in Vaccines and Molecular Therapeutics

Jesús I. Gil-Chinchilla
Carlos Bueno
Carlos M. Martínez
Ana Ferrández-Múrtula
Ana M. García-Hernández
Miguel Blanquer
Mar Molina-Molina
Agustín G. Zapata
Robert Sackstein
Jose M. Moraleda

Frontiers in Immunology

doi 10.3389/fimmu.2024.1385691

1,285 views

Original Research

Published on 27 Mar 2024

Modular design of bi- and multi-specific knob domain fusions

in Vaccines and Molecular Therapeutics

Mikhail Kuravsky
Glyn F. Gibbons
Callum Joyce
Anthony Scott-Tucker
Alex Macpherson
Alastair D. G. Lawson

Frontiers in Immunology

doi 10.3389/fimmu.2024.1384467

2,593 views

Navigation group

Articles

Designing of a multi-epitopes based vaccine against Haemophilius parainfluenzae and its validation through integrated computational approaches

Prevalence and genetic diversity of rotavirus among children under 5 years of age in China: a meta-analysis

The role of cGAMP via the STING pathway in modulating germinal center responses and CD4 T cell differentiation

Unifying global efforts by CEPI’s centralized laboratory network

Bi-isotype immunoglobulins enhance antibody-mediated neutrophil activity against Plasmodium falciparum parasites

Outer membrane vesicles derived from Bordetella pertussis are potent adjuvant that drive Th1-biased response

Utilizing noncatalytic ACE2 protein mutant as a competitive inhibitor to treat SARS-CoV-2 infection

An in vitro assay for toxicity testing of Clostridium perfringens type C β-toxin

Investigation of the safety and protective efficacy of an attenuated and marker M. bovis-BoHV-1 combined vaccine in bovines

Dry and liquid formulations of IBT-V02, a novel multi-component toxoid vaccine, are effective against Staphylococcus aureus isolates from low-to-middle income countries

Boosting the immunogenicity of the CoronaVac SARS-CoV-2 inactivated vaccine with Huoxiang Suling Shuanghua Decoction: a randomized, double-blind, placebo-controlled study

Whole genome sequencing of recombinant viruses obtained from co-infection and superinfection of Vero cells with modified vaccinia virus ankara vectored influenza vaccine and a naturally occurring cowpox virus

Clonal structure and the specificity of vaccine-induced T cell response to SARS-CoV-2 Spike protein

Co-formulation of the rF1V plague vaccine with depot-formulated cytokines enhances immunogenicity and efficacy to elicit protective responses against aerosol challenge in mice

Optimizing cryopreservation conditions for use of fucosylated human mesenchymal stromal cells in anti-inflammatory/immunomodulatory therapeutics

Modular design of bi- and multi-specific knob domain fusions